True Leaf Medicine International Ltd has appointed Dr. Katherine Kramer as Founding Chair of its Veterinary Advisory Board.
Dr. Kramer, who has been a vocal advocate for the research and therapeutic use of cannabis for animals, is the Medical Director at the VCA-Canada Vancouver Animal Wellness Hospital.
She has become a resource for veterinarians across North America seeking information on the benefits of medicinal cannabis for pets.
True Leaf Founder, Darcy Bomford, says Dr. Kramer’s specific knowledge on the safe use, dosage, and efficacy related to administering cannabis for pets will be key to the success of the company’s upcoming cannabidiol product line, scheduled to be launched to the veterinary market next year.
Dr. Kramer will recruit veterinarians from around the world to join True Leaf as the company develops legal and safe medicinal cannabis products for pets.
She and her colleagues will be instrumental in the research and development of CBD pet products at True Leaf, including the design and execution of supportive trials and the development of education programs for veterinarians and pet owners on the best use of cannabis products for pets.
“True Leaf has established itself as a leader in the pet supplement industry by committing to getting it right and developing products that are safe and effective,” said Dr. Kramer. “By assembling a group of top clinicians, together with True Leaf’s committed team, I look forward to developing industry-leading therapeutic pet products and being on the forefront of cannabis education and research. Ultimately, it’s about returning the love – improving the quality of life for our dearest pet companions with medicinal cannabis.”
Dr. Kramer is a member of the Canadian Veterinary Medical Association (CVMA), the College of Veterinarians of British Columbia, the International Veterinary Academy of Pain Management, the International Veterinary Acupuncture Society, and the American Association of Feline Practitioners.
She is also a member of the Canadian Association of Veterinary Cannabinoid Medicine (CAVCM), an organization that is working with the CVMA to encourage Health Canada to amend the Access to Cannabis for Medical Purposes Regulations (ACMPR) to permit the future classification of CBD as a Veterinary Health Product.